309 related articles for article (PubMed ID: 33306077)
1. A dissolving and glucose-responsive insulin-releasing microneedle patch for type 1 diabetes therapy.
Zhang Y; Wu M; Tan D; Liu Q; Xia R; Chen M; Liu Y; Xue L; Lei Y
J Mater Chem B; 2021 Jan; 9(3):648-657. PubMed ID: 33306077
[TBL] [Abstract][Full Text] [Related]
2. Glucose-Responsive Gold Nanocluster-Loaded Microneedle Patch for Type 1 Diabetes Therapy.
Zhang Y; Li J; Wu M; Guo Z; Tan D; Zhou X; Li Y; Liu S; Xue L; Lei Y
ACS Appl Bio Mater; 2020 Dec; 3(12):8640-8649. PubMed ID: 35019634
[TBL] [Abstract][Full Text] [Related]
3. Assisted 3D printing of microneedle patches for minimally invasive glucose control in diabetes.
Wu M; Zhang Y; Huang H; Li J; Liu H; Guo Z; Xue L; Liu S; Lei Y
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111299. PubMed ID: 32919660
[TBL] [Abstract][Full Text] [Related]
4. Formulation of two-layer dissolving polymeric microneedle patches for insulin transdermal delivery in diabetic mice.
Lee IC; Lin WM; Shu JC; Tsai SW; Chen CH; Tsai MT
J Biomed Mater Res A; 2017 Jan; 105(1):84-93. PubMed ID: 27539509
[TBL] [Abstract][Full Text] [Related]
5. The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin.
Liu S; Jin MN; Quan YS; Kamiyama F; Katsumi H; Sakane T; Yamamoto A
J Control Release; 2012 Aug; 161(3):933-41. PubMed ID: 22634072
[TBL] [Abstract][Full Text] [Related]
6. High drug-loading gold nanoclusters for responsive glucose control in type 1 diabetes.
Zhang Y; Wu M; Dai W; Chen M; Guo Z; Wang X; Tan D; Shi K; Xue L; Liu S; Lei Y
J Nanobiotechnology; 2019 Jun; 17(1):74. PubMed ID: 31159842
[TBL] [Abstract][Full Text] [Related]
7. A self-adherent, bullet-shaped microneedle patch for controlled transdermal delivery of insulin.
Seong KY; Seo MS; Hwang DY; O'Cearbhaill ED; Sreenan S; Karp JM; Yang SY
J Control Release; 2017 Nov; 265():48-56. PubMed ID: 28344013
[TBL] [Abstract][Full Text] [Related]
8. Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats.
Ling MH; Chen MC
Acta Biomater; 2013 Nov; 9(11):8952-61. PubMed ID: 23816646
[TBL] [Abstract][Full Text] [Related]
9. Insulin delivery systems combined with microneedle technology.
Jin X; Zhu DD; Chen BZ; Ashfaq M; Guo XD
Adv Drug Deliv Rev; 2018 Mar; 127():119-137. PubMed ID: 29604374
[TBL] [Abstract][Full Text] [Related]
10. Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery.
Yu J; Zhang Y; Ye Y; DiSanto R; Sun W; Ranson D; Ligler FS; Buse JB; Gu Z
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8260-5. PubMed ID: 26100900
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and H
Yu J; Qian C; Zhang Y; Cui Z; Zhu Y; Shen Q; Ligler FS; Buse JB; Gu Z
Nano Lett; 2017 Feb; 17(2):733-739. PubMed ID: 28079384
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of biodegradable composite microneedles based on calcium sulfate and gelatin for transdermal delivery of insulin.
Yu W; Jiang G; Liu D; Li L; Chen H; Liu Y; Huang Q; Tong Z; Yao J; Kong X
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():725-734. PubMed ID: 27987766
[TBL] [Abstract][Full Text] [Related]
13. Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon.
GhavamiNejad A; Li J; Lu B; Zhou L; Lam L; Giacca A; Wu XY
Adv Mater; 2019 Jul; 31(30):e1901051. PubMed ID: 31165524
[TBL] [Abstract][Full Text] [Related]
14.
Tort S; Mutlu Agardan NB; Han D; Steckl AJ
J Microencapsul; 2020 Nov; 37(7):517-527. PubMed ID: 32783663
[TBL] [Abstract][Full Text] [Related]
15. Innovative transdermal delivery of insulin using gelatin methacrylate-based microneedle patches in mice and mini-pigs.
Demir B; Rosselle L; Voronova A; Pagneux Q; Quenon A; Gmyr V; Jary D; Hennuyer N; Staels B; Hubert T; Abderrahmani A; Plaisance V; Pawlowski V; Boukherroub R; Vignoud S; Szunerits S
Nanoscale Horiz; 2022 Jan; 7(2):174-184. PubMed ID: 35039816
[TBL] [Abstract][Full Text] [Related]
16. Microneedle-based insulin transdermal delivery system: current status and translation challenges.
Zhao J; Xu G; Yao X; Zhou H; Lyu B; Pei S; Wen P
Drug Deliv Transl Res; 2022 Oct; 12(10):2403-2427. PubMed ID: 34671948
[TBL] [Abstract][Full Text] [Related]
17. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery.
Migalska K; Morrow DI; Garland MJ; Thakur R; Woolfson AD; Donnelly RF
Pharm Res; 2011 Aug; 28(8):1919-30. PubMed ID: 21437789
[TBL] [Abstract][Full Text] [Related]
18. Dual self-regulated delivery of insulin and glucagon by a hybrid patch.
Wang Z; Wang J; Li H; Yu J; Chen G; Kahkoska AR; Wu V; Zeng Y; Wen D; Miedema JR; Buse JB; Gu Z
Proc Natl Acad Sci U S A; 2020 Nov; 117(47):29512-29517. PubMed ID: 33177238
[TBL] [Abstract][Full Text] [Related]
19. Erythrocyte-Membrane-Enveloped Biomineralized Metal-Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery.
He M; Yu P; Hu Y; Zhang J; He M; Nie C; Chu X
ACS Appl Mater Interfaces; 2021 May; 13(17):19648-19659. PubMed ID: 33890785
[TBL] [Abstract][Full Text] [Related]
20. Glucose-responsive insulin microneedle patches for long-acting delivery and release visualization.
He Y; Chen N; Zang M; Zhang J; Zhang Y; Lu H; Zhao Q; Mao Y; Yuan Y; Wang S; Gao Y
J Control Release; 2024 Apr; 368():430-443. PubMed ID: 38447813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
